Pharma News HQ – Magazine for Pharma Sector

Sun Pharma recalls over 34k bottles of generic drug in US due to manufacturing issues

February 14, 2023 0

Drug major Sun Pharma is recalling over 34,000 bottles of a generic medication, used to treat high blood pressure, in the US market due to failed dissolution testing. As per the US Food and Drug […]

Genenta Science signs manufacturing deal with AGC Biologics

February 14, 2023 0

Genenta Science and AGC Biologics have signed a development and manufacturing service agreement (MSA). Under the deal, AGC Biologics will be responsible for manufacturing the cell therapy lentivirus-based product for the ongoing clinical programmes of […]

Vial and Egnyte announce partnership for eTMF solution integration

February 14, 2023 0

Tech-enabled, next-generation contract research organisation (CRO) Vial has announced a partnership to integrate Egnyte’s Life Sciences electronic trial master file (eTMF) solution into its clinical trial platform. Egnyte eTMF minimises document processing times and maintains […]

SOPHiA GENETICS and AstraZeneca partner for oncology drugs development

February 14, 2023 0

SOPHiA GENETICS is expanding its collaboration with AstraZeneca to include multimodal approaches for developing cancer drugs. This collaboration aims to use the global SOPHiA DDM platform, a cloud-native platform of SOPHiA GENETICS, and multimodal algorithmic […]

FDA suggests ways to curb constraints with rare disease gene therapy trials

February 14, 2023 0

OIn 2022, 54% of FDA new drug approvals were for rare diseases, a significant increase in proportion of approvals in the recent years. At the town hall, Dr. Melanie Blank, a primary reviewer at the […]

Vial and Egnyte announce partnership for eTMF solution integration

February 14, 2023 0

FDA suggests ways to curb constraints with rare disease gene therapy trials

February 14, 2023 0

Storm receives Innovate UK grant for development of SARS-CoV-2 drugs

May 5, 2022 0

Storm Therapeutics has received a Biomedical Catalyst grant from Innovate UK for carrying out research and development of new therapies against a SARS-CoV-2 protein. For drug development, the company will leverage its ribonucleic acid (RNA) […]

EC approves Horizon’s Uplizna for neuromyelitis optica spectrum disorder

May 5, 2022 0

The European Commission (EC) has granted approval for Horizon Therapeutics’ Uplizna (inebilizumab) as monotherapy to treat neuromyelitis optica spectrum disorder (NMOSD) in adults. The treatment is intended for NMOSD patients who are anti-aquaporin-4 immunoglobulin G […]

EC approves Sanofi and Regeneron’s Dupixent for severe asthma in children

April 14, 2022 0

The European Commission (EC) has updated the marketing authorization for Sanofi and Regeneron’s Dupixent (adupilumab) to include as an add-on maintenance treatment for severe asthma with type 2 inflammation in children of the age six […]

SOPHiA GENETICS and AstraZeneca partner for oncology drugs development

February 14, 2023 0

Genesis and Lilly partner to discover new drugs for up to five targets

May 5, 2022 0

Genesis Therapeutics and Eli Lilly and Company have signed a strategic partnership for discovering new drugs for up to five targets across various therapeutic areas. The alliance will leverage the artificial intelligence (AI) drug discovery […]

Elektrofi and IPA to collaborate for Covid-19 antibody development

March 17, 2022 0

Elektrofi has entered a partnership with ImmunoPrecise Antibodies (IPA) for developing a high-concentration formulation of the latter’s Covid-19 antibody cocktail, PolyTope TATX-03. The alliance intends to produce a data package required for filing an investigational […]

MGH and BWH identify multi-inflammatory syndrome drug for children

March 3, 2022 0

Massachusetts General Hospital (MGH) and Brigham and Women’s Hospital (BWH) researchers have identified a potential drug candidate, larazotide acetate, to treat serious Covid-19 complication, multi-inflammatory syndrome (MIS-C) in children. A rare, severe and possibly life-threatening […]

Trending